1. Home
  2. ASX vs ONC Comparison

ASX vs ONC Comparison

Compare ASX & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ASE Technology Holding Co. Ltd. (each representing Two)

ASX

ASE Technology Holding Co. Ltd. (each representing Two)

HOLD

Current Price

$15.55

Market Cap

35.8B

Sector

Technology

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$311.76

Market Cap

34.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASX
ONC
Founded
1984
2010
Country
Taiwan
Switzerland
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.8B
34.8B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
ASX
ONC
Price
$15.55
$311.76
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$369.50
AVG Volume (30 Days)
6.1M
269.5K
Earning Date
02-12-2026
11-06-2025
Dividend Yield
1.68%
N/A
EPS Growth
6.31
N/A
EPS
0.25
0.58
Revenue
$20,657,920,055.00
$4,972,687,000.00
Revenue This Year
$9.63
$895.40
Revenue Next Year
$13.98
$22.04
P/E Ratio
$28.14
$503.22
Revenue Growth
6.07
50.43
52 Week Low
$6.94
$172.67
52 Week High
$16.51
$385.22

Technical Indicators

Market Signals
Indicator
ASX
ONC
Relative Strength Index (RSI) 56.63 41.88
Support Level $14.72 $306.61
Resistance Level $16.51 $318.12
Average True Range (ATR) 0.31 8.43
MACD -0.08 -0.78
Stochastic Oscillator 45.25 36.90

Price Performance

Historical Comparison
ASX
ONC

About ASX ASE Technology Holding Co. Ltd. (each representing Two)

ASE Technology Holding Co Ltd is a semiconductor assembly and testing firm. The company operates in segments: Packaging, Testing, and Electronic Manufacturing Services. Of these, Packaging segment contribute the maximum revenue. The packaging segment involves packaging bare semiconductors into completed semiconductors with improved electrical and thermal characteristics. The Testing Segment includes front-end engineering testing, wafer probing, and final testing services. In the EMS segment, the company designs manufactures, and sells electronic components and telecommunication equipment motherboards. The company is based in Taiwan but garners over half its sales from firms in the United States.

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

Share on Social Networks: